Michael J. Wasserman
Michael joined H.I.G. Ventures in 2004 and focuses on investments in therapeutics and medical devices. Michael is involved in all stages of the investment process.
Prior to joining H.I.G., Michael was a principal at Innovations Foundation, a firm focused on the creation, financing and growth of high technology companies in the life sciences, information technology and engineering sectors. At Innovations Foundation, Michael was instrumental in building multiple high growth companies based on technology derived from academic or federally sponsored research programs. Michael has also held prominent roles in several entrepreneurial and venture-backed life sciences companies, including CELLutions Biosystems, where he served as Vice President, Business Development. Earlier in his career, Michael worked directly for, or as a consultant to, corporate finance institutions, pharmaceutical companies and clinical research organizations.
Michael serves as a board observer for H.I.G. portfolio companies HyperBranch Medical Technology, Tranzyme Pharma, OncoGeneX and CardioFocus.
Michael received his B.Sc. from McGill University in Montreal, Canada and his Ph.D. from the University of Toronto.